| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Process Dev, Manufacturing
1 company
Paul Sauer last filed a Form 4 in December 2022, as SVP Process Dev, Manufacturing at PCVX. Paul Sauer's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Paul Sauer's trades have earned a below-average insider score of 43/100 across 11 rated trades. Over a 12-month horizon, 18.2% of those trades were profitable, with an average 12-month return of -63.8%.
At the last filing, the largest reported position was 13,822 shares of PCVX. The PCVX filings lean toward selling, a net 45,807 shares.
Paul Sauer has 18 Form 4 filings on record from January 2021 to December 2022, all as SVP Process Dev, Manufacturing at Vaxcyte (PCVX), 2021–2022.
The 28 reported transactions were 15 open-market sales, 5 other transactions, 3 option or other derivative awards and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 13 sales worth about $1.2M.
The largest open-market sale was 6,000 shares of PCVX at an average $25.00 on March 10, 2022, about $150K. Twelve months later PCVX was up 52%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.93 | $77,784.90 | -17.0% | +71.4% | +89.7% | |
| Jul 27, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -14.5% | +40.5% | +86.3% | |
| Jul 20, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -12.7% | +0.6% | +93.3% | |
| May 23, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $26.22 | $78,670.50 | -11.2% | -2.0% | +90.1% | |
| Apr 22, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -10.7% | -0.1% | +80.5% | |
| Mar 22, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -9.6% | -19.4% | +46.8% | |
| Mar 10, 2022 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 6,000 | $25.00 | $150,000.00 | -16.2% | -17.1% | +51.7% | |
| Dec 29, 2021 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 6,000 | $25.00 | $150,000.00 | -18.1% | +2.9% | +97.3% | |
| Nov 1, 2021 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.00 | $75,000.00 | -8.3% | -23.8% | +80.1% | |
| Sep 22, 2021 | PCVX Vaxcyte, Inc. | SVP Process Dev, Manufacturing | Sell | 5,307 | $25.20 | $133,724.19 | -12.8% | -11.5% | -4.1% |